JHS Svendgaard Laboratories share news and announcements
NSE: JHSBSE: 532771Personal ProductsSmall Cap
Last close ₹8.41down ₹0.44 (4.97%)BSE ₹8.49
Share price at the NSE close on 23 Oct 2026. Previous close ₹8.85.
52-week range of traded prices to 23 Oct 2026
₹6.26Low, 30 Mar 2026₹13.90High, 27 Oct 2025
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹74 Cr3,087th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 Jul 2026
- 0.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- −1.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- −2.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 Jul 2026
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day.
- 63,248
JHS Svendgaard Laboratories share news and announcements
677 announcements, routine notices left out, newest first. Page 14 of 14.
Mar 2008
27 Mar · Business
Board of Directors in their meeting held on March 26, 2008 has allotted 4,00,000 Equity Shares of Rs.10/- each and 16,00,000 Warrants convertible into Equity Shares of Rs.10 each on Preferential basis. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Mar · Business
Board of Directors in their meeting held on March 26, 2008 has allotted 4,00,000 equity shares of Rs.10/- each and 16,00,000 warrants convertible into equity shares of Rs. 10 each on preferential basis. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
13 Feb · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31, 2007 and found the same to be in order subject to certain observations. The auditor's observations are: Non-disclosure of all prescribed information under Accounting Standard 17 on "Segment Reporting" issued by ICAI.
Jan 2008
30 Jan · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31,2007 (taken on record by the Board of Directors of the Company at its meeting held on January 29, 2008) regarding the details of funds raised through IPO and Utilization of such funds. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jan · Board meeting
Meeting on 29 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”4 Jan · Meeting
Proceedings of the Extra Ordinary General Meeting of the shareholders of the company held on January 03, 2008.. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2007
11 Dec · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30, 2007 and found the same to be in order subject to certain observations. The auditor's observations are: Non disclosure of information as required to be disclosed in the manner as prescribed under Clause 41 of the Listing Agreement and Accounting Standard 17 on "Segment Reporting" issued by ICAI.4 Dec · Meeting
Jhs Svendgaard Laboratories Limited had informed the Exchange regarding the Outcome of the Board Meeting held on December 03, 2007. The Company has now informed the Exchange that the date of Extra Ordinary General Meeting was written as December 29, 2007 by mistake. The date of Extra Ordinary General Meeting should be read as January 03, 2008. The notice should be read as follows: "The Board of Directors of the company in their meeting held today on December 3, 2007 have decided to allot 16,00,000 warrants which will be converted into Equity shares at the option of the holders, to the persons belonging to the Promoter and non-promoter group. Alongwith the Convertible Warrants, the Board has also decided to allot 4,00,000 Equity shares to the strategic investor belonging to Non-promoter group. Both allotments will be subject to the shareholders approval, the Extra Ordinary General Meeting for which is decided to be called on January 3, 2008".4 Dec · Board meeting
The Board of Directors of the company in their meeting held today on 3rd Dec,2007 have decided to allot 16,00,000 warrants which will be converted into Equity shares at the option of the holders,to the persons belonging to the Promoter and Non-Promoter group. Alongwith the Convertible Warrants, the Board has also decided to allot 4,00,000 Equity shares to the strategic investor belonging to Non-Promoter group. Both allotments will be subject to the shareholders approval, the Extra Ordinary General Meeting for which is decided to be called on 29th Dec, 2007
Nov 2007
27 Nov · Board meeting
Inter-alia to consider the issue of Equity Shares / Warrants of the Company to the Promoter, Person in Promoter Group and other Investors on preferential basis.26 Nov · Miscellaneous
JHS Svendgaard Laboratories Limited have received the Top Exporter of Toothbrushes including Dental Plate Brushes from India award again FOURTH time in a row, from 'The Plastics Export Promotion Council (PLEX)', sponsored by Ministry of Commerce, Government of India23 Nov · Miscellaneous
Jhs Svendgaard Laboratories Limited has set up a new subsidiary in the Ras-Al-Khaimah, Free Trade Zone, UAE with the name "Jones H Smith FZE". The Company is formed as Free Trade Zone Establishment. The subsidiary shall initially be engaged in Import, Export and Trading of Oral Care Products and Personal Care Products. This will explore the new oppurtunities in the International Market and will expand the business of the Company globally.
Oct 2007
24 Oct · Board meeting
Meeting on 31 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”9 Oct · Change in Company Secretary/Compliance Officer
Vide its letter dated October 06, 2007 that Mr. Naveen Bhatnagar, the Company Secretary and Compliance Officer of the Company has resigned with effect from October 01, 2007. Further, Mr. Jagmohan Bijalwan is appointed as Company Secretary and Compliance Officer of the Company with effect from October 01, 2007.1 Oct · Meeting
Annual General Meeting of the Shareholders of the Company was held on September 29, 2007. Further, the company has submitted to the Exchange a copy of the proceeding of the Annual General Meeting of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2007
24 Sep · Management
Vide its letter dated September 20, 2007 that Shri J.K. Rao, Director has tendered resignation vide letter dated August 22, 2007. The Board of Directors of the Company in its meeting held on September 20, 2007 have considered the request of Mr. J.K. Rao and accepted his resignation from the Directorship of the Company with immediate effect.7 Sep · Meeting
Annual General Meeting of the Members of the Company will be held on September 29, 2007 and the Register of Members and Share Transfer of the Company shall remain closed from September 25, 2007 to September 29, 2007 (both days inclusive).
Aug 2007
1 Aug · Utilisation of Funds
Details of funds raised through IPO and utilization of such funds. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
20 Jul · Board meeting
Meeting on 31 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”3 Jul · Utilisation of Funds
Details of Funds raised through IPO and utilization of such funds. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2007
25 Jun · Board meeting
To inter-alia, consider and adopt the audited financial results for the year ended March 31, 2007.
Apr 2007
18 Apr · Results
(1) Shri Gopal Krishan Nanda has been appointed as a Whole-time Director on the Board of Directors of our Company w.e.f. 24.03.2007. (2) Shri P.K.Manglik has resigned w.e.f. 24.03.2007 and he ceased to be a whole-time Director of our Company w.e.f. 24.03.2007. (3) The Company has started Commercial Operations/Production on 02.04.2007 of Unit at Kala-amb, District Sirmour in the State of Himachal Pradesh. (4) The Company has on 10.04.2007 acquired 9400 equity shares of Rs.10/- each of M/s Nikiven Personal Care Products Private Ltd constituting 51.08% of its paid-up Capital, and has accordingly become a subsidiary of our Company w.e.f. 10.04.2007. (5) It is informed that the Company will publish audited results within a period of 3 months from the end of last quarter of the financial year. As such, we are not publishing/giving to the stock Exchange/s results for the last quarter of the financial year 31st March 2007
Mar 2007
22 Mar · Limited Review Report
Auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2006. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements). For more details click here.14 Mar · Management
Shri Polavaram Vanamali IAS (retd) has been appointed as Director of our Company with effect from 2nd February 2007.
Feb 2007
12 Feb · Management
Shri Naveen Bhatnagar has assumed the charge of the post of Company Secretary of the Company with effect from 30th January, 2007
Jan 2007
19 Jan · Utilisation of Funds
Details of utilisation of IPO proceeds are as under: I) Expansion Plan/New Project:- 1) Building and civil works - Utilisation as projected in the Prospectus (Rs. in lakhs)- 766.88, Actual as on 31.12.2006 (Rs. in lakhs)- 35.22; 2) Plant & Machinery - Utilisation as projected in the Prospectus (Rs. in lakhs)- 4013.14, Actual as on 31.12.2006 (Rs. in lakhs)- 86.80; 3) Margin money for working capital - Utilisation as projected in the Prospectus (Rs. in lakhs)- 160.25, Actual as on 31.12.2006 (Rs. in lakhs)- 160.25; 4) Contingencies - Utilisation as projected in the Prospectus (Rs. in lakhs)- 237.13, Actual as on 31.12.2006 (Rs. in lakhs - 35.96. II) General Corporate Purposes - Utilisation as projected in the Prospectus (Rs. in lakhs)- 445.60, Actual as on 31.12.2006 (Rs. in lakhs)- 378.31. III) Issue Expenses - Utilisation as projected in the Prospectus (Rs. in lakhs)- 413.00, Actual as on 31.12.2006 (Rs. in lakhs)- 366.82. Total - Utilisation as projected in the Prospectus (Rs. in lakhs)- 6036.00, Acutal as on 31.12.2006 (Rs. in lakhs)- 1063.36.15 Jan · Board meeting
Meeting on 15 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”